Orchestra BioMed Holdings, Inc. Board of Directors

Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension (HTN); and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold devices and minimally invasive surgery devices. The company has a collaboration agreement with Medtronic, Inc. for the development and commercialization of BackBeat CNT for the treatment of HTN in patients indicated for a cardiac pacemaker; and a strategic collaboration with Terumo Medical Corporation for the development and commercialization of Virtue SAB for the treatment of coronary and peripheral artery disease. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.

Mr. David P. Hochman

Mr. David P. Hochman

Founder, Chairman of the Board of Directors & CEO

Mr. Bob Laughner

Mr. Bob Laughner

Senior Vice President of Regulatory & Quality

Dr. Avraham Matityahu Fischer M.D.

Dr. Avraham Matityahu Fischer M.D.

Senior Vice President of Medical Affairs & Innovation

Dr. George Papandreou Ph.D.

Dr. George Papandreou Ph.D.

GM & Senior VP of Focal Therapies

Mr. William Reed Little

Mr. William Reed Little

Executive Vice President of Corporate Development & Strategy

Mr. Darren R. Sherman

Mr. Darren R. Sherman

Founder, President, COO & Director

Dr. Yuval Hay Mika D.Sc, Ph.D.

Dr. Yuval Hay Mika D.Sc, Ph.D.

GM & CTO of Bioelectronic Therapies

Mr. Juan Lorenzo

Mr. Juan Lorenzo

Senior Vice President of Product Development

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.